Sanchit Chawla

Sanchit Chawla

Auto-generated profile, based on publicly available information

Sanchit Chawla

Cleveland Clinic, Cleveland, OH, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2023 in Chest
Verified
Journal Article
Closed access
SDSiddharth Dugar
Siddharth Dugar
RSRyota Sato
Ryota Sato
SCSanchit Chawla
Sanchit Chawla
JYJee Young You
Jee Young You
XWXiaofeng Wang
Xiaofeng Wang
ADAbhijit Duggal
Abhijit Duggal

15 November 2022 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
YSYasser M. Sammour
Yasser M. Sammour
HLHassan Lak
Hassan Lak
JCJohnny Chahine
Johnny Chahine
Abdelrahman AbushoukAbdelrahman Abushouk
Abdelrahman Abushouk
SCSanchit Chawla
Sanchit Chawla
SKSamir R. Kapadia
Samir R. Kapadia

1 December 2021 in The American Journal of Cardiology
Verified
Journal Article
Closed access
HLHassan Mehmood Lak
Hassan Mehmood Lak
SCSanchit Chawla
Sanchit Chawla
RGRama D. Gajulapalli
Rama D. Gajulapalli
BVBeni Rai Verma
Beni Rai Verma
AVAdil Fethi Vural
Adil Fethi Vural
SKSamir R. Kapadia
Samir R. Kapadia

28 September 2022 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
RNRaunak M. Nair
Raunak M. Nair
SKSachin Kumar
Sachin Kumar
TSTalha Saleem
Talha Saleem
SCSanchit Chawla
Sanchit Chawla
AVAdil Vural
Adil Vural
VMVenu Menon
Venu Menon

4 October 2024 in JACC: Advances
Verified
Journal Article
Open access
RNRaunak M. Nair
Raunak M. Nair
SCSanchit Chawla
Sanchit Chawla
FAFeras Alkhalaileh
Feras Alkhalaileh
BABahaa Abdelghaffar
Bahaa Abdelghaffar
ABAgam Bansal
Agam Bansal
VMVenu Menon
Venu Menon
The clinical characteristics and outcomes of patients who develop cardiogenic shock (CS) secondary to primary valvular dysfunction (valvular cardiogenic shock [VCS]) remain unclear. The purpose of this study was to describe the cohort of patients with VCS and understand their outcomes compared to other forms of CS. All patients admitted to Cleveland Clinic cardiac intensive care unit between January 1, 2010, and December 31, 2021, with a diagnosis of CS were retrospectively identified. Characteristics and outcomes for shock patients with VCS were compared to those without VCS. A total of 2,754 patients were admitted to our cardiac intensive care unit with CS, of which 442 (16%) had VCS. The median age of patients with VCS was higher than those with non-VCS (70 years vs 64 years, P < 0.001) and were more likely females (40.3% vs 32.1%, P = 0.001). VCS was predominantly due to native valve dysfunction as compared to prosthetic valve dysfunction (71% vs 29%, P < 0.001), with the aortic valve noted to be the most common valve affected. Patients with VCS had higher 1-year (44% vs 37%, P < 0.001) and 30-day all-cause mortality (28% vs 20%, P < 0.001) compared to those without VCS. When compared to percutaneous intervention and medical therapy alone, surgical intervention in VCS was associated with the best short- and long-term outcomes (P < 0.001). VCS is associated with poor short and long outcomes. Native valvular dysfunction and aortic valve involvement account for the majority of patients with VCS. Definitive surgical therapy and expanding the role of percutaneous therapies may be pivotal in improving clinical outcomes in this high-risk cohort.

4 March 2022 in Transplantation Proceedings
Verified
Journal Article
Closed access
SCSanchit Chawla
Sanchit Chawla
HLHassan Mehmood Lak
Hassan Mehmood Lak
YSYasser Sammour
Yasser Sammour
TATaha Ahmed
Taha Ahmed
DGDeepthi Gunasekaran
Deepthi Gunasekaran
SKSamir Kapadia
Samir Kapadia